Intriguingly, when concurrent (Platin + Taxol) treatment and prognostic significance were analyzed, the data showed that high expression of AQP0 and AQP1 mRNA were correlated to decrease survival rate and high expression of AQP3, AQP6, and AQP11 were correlated to good OS in ovarian cancer patients. Here, AQP1 is linked to ovarian carcinoma.